First-of-its-Kind clinic opens to track silent blood condition linked to cancer and heart disease

NCT ID NCT07313059

Summary

This study aims to understand the long-term health of people with clonal hematopoiesis (CH), a common blood condition in older adults that increases the risk of blood cancers and heart disease. Researchers will monitor 100 participants over time in Australia's first dedicated CH clinic, tracking their health, providing support, and building a database to guide future care. The goal is to learn how to best manage this condition, which is often found by chance but currently has no specific treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLONAL HEMATOPOIESIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Canberra Health Services

    RECRUITING

    Canberra, Australian Capital Territory, 2605, Australia

    Contact

Conditions

Explore the condition pages connected to this study.